Table 3 Expression levels of phosphorylated AKT, mTOR, S6RP and 4EBP1 (n = 18)
Targets | IHC score no. cases | Positive rate | |||
|---|---|---|---|---|---|
0 | 1 | 2 | 3 | ||
Phospho-AKT | 7 | 3 | 5 | 3 | 61.1% |
Phospho-mTOR | 4 | 4 | 7 | 3 | 77.8% |
Phospho-S6RP | 3 | 8 | 4 | 3 | 83.3% |
Phospho-4EBP1 | 3 | 4 | 6 | 5 | 83.3% |
Targets | IHC score no. cases | Positive rate | |||
|---|---|---|---|---|---|
0 | 1 | 2 | 3 | ||
Phospho-AKT | 7 | 3 | 5 | 3 | 61.1% |
Phospho-mTOR | 4 | 4 | 7 | 3 | 77.8% |
Phospho-S6RP | 3 | 8 | 4 | 3 | 83.3% |
Phospho-4EBP1 | 3 | 4 | 6 | 5 | 83.3% |